SCHEMBL6972522

SCHEMBL6972522

O=C(Nc1ccc(Cl)cc1)OCc1ccc(Cc2c[nH]cn2)cc1

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.53
RAB9A P51151 2/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
CYP1A2 P05177 4/20 0.46
CYP2C9 P11712 4/20 0.46
POLB P06746 3/20 0.46
CYP2C19 P33261 3/20 0.46
MAPT P10636 2/20 0.46
CYP2D6 P10635 2/20 0.46
LMNA P02545 1/20 0.46
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
NPSR1 Q6W5P4 1/20 0.45
ROCK2 O75116 1/20 0.45
SCD O00767 1/20 0.45
GAA P10253 1/20 0.43
CYP3A4 P08684 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6972709 0.89 NPC1 (0.52) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C9
SCHEMBL9029314 0.89 NPC1 (0.52) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C9
SCHEMBL6968612 0.88 ROCK2 (0.47) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C9
SCHEMBL6972421 0.88 POLB (0.54) NPC1RAB9ASMN1; SMN2POLBMAPT
SCHEMBL6960634 0.83 KMT2A (0.50) NPC1RAB9ACYP1A2CYP2C9CYP2C19
SCHEMBL6958769 0.83 POLB (0.45) SMN1; SMN2CYP1A2CYP2C9POLBCYP2C19
SCHEMBL6961218 0.83 KMT2A (0.50) NPC1RAB9ACYP1A2CYP2C9CYP2C19
SCHEMBL31043961 0.81 NPC1 (0.77) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C9
SCHEMBL6971039 0.81 MEN1 (0.43) NPC1CYP1A2CYP2C9POLBCYP2C19
SCHEMBL6966124 0.80 ROCK2 (0.47) NPC1RAB9ASMN1; SMN2CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729459-B1 PHENYL-ALKYL IMIDAZOLES AS H3-RECEPTOR ANTAGONISTS SCHERING CORP (US) 2003-03-12 EP disclosed
US-5578616-A ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, TREATMENT FOR GASTROINTESTINAL AND CARDIOVASCULAR DISORDERS SCHERING CORPORATION (US) 1996-11-26 US disclosed